D-Limonene is a naturally occurring biodegradable solvent and is one of the most common citrus terepenes. It is a major constituent in many citrus oils and is commonly found in lemons, oranges, mandarin, lime and grapefruit. Limonene is available in the market in the form of commercial juices for consumption as well as in fragrances due to its volatile nature and lemony aroma. The D-Limonene products market is expected to grow at a rapid rate due to its varying applications in the health, dietary, cleaning and chemical industries.

D-Limonene is an effective and relatively safe cleaning solvent, and is used in many industries as a cleansing agent especially in industries that use oil and grease extensively. As the limonene is and organic solvent it performs better than water based solvent and can be utilized as a no caustic and nonreactive surface cleaner. The de limonene market is driven by various factors such as its anti-rusting and anti-corrosive properties, its varied applications in industrial cleaning and its bio degradable and organic nature. The increase in awareness about human safety in working environment and the rising environmental concerns are also driving the limonene market as it is neither hazardous to users nor an environmental pollutant. The growing demand for aerosol propellants and petrochemical derived solvents is expected to further boost the D-Limonene market in coming years. As the limonene is currently regulated as a volatile organic compound (VOC), its usage is graded as nontoxic and hazardous.

There has been a steep increase in the popularity of personal care products and cleansers owing to health concerns culminating into a growing demand for dietary supplements. D-Limonene has many anti-oxidant properties and is non carcinogenic or mutagenic, which makes it an ideal option for numerous supplements and medicinal nutrients. This is helping the limonene find novel applications everyday leading to market growth.

Browse Details of Report @ https://www.hexaresearch.com/upcoming-research/d-limonene-market

The global RSV Diagnostics market is categorized on the basis of products, end use, and regions. On the basis of products, the segments are DFA (direct fluorescence antibody) method, RADTs (rapid antigen diagnostic tests), flow cytometry, molecular diagnostics, gel microdroplets, diagnostic imaging, chromatographic immunoassay, and others. Due to high accuracy & precision, the molecular diagnostics segment may lead the overall industry during the forecast period.

Based on end uses, the industry is divided into clinics, hospitals, homecare, and laboratory. Hospitals held the largest share in 2015. It is expected that this segment will continue dominating the RSV Diagnostics market because of high hospitalization rate of RSV infected patients. “Homecare” too may expand significantly in the forthcoming years because of high demand for perinatal & in-house testing. Surging popularity of homecare services owes to high governmental investments in training programs for the same.

Geographically, the global Respiratory Syncytial Virus Diagnostics Market is segmented into Latin America, Europe, North America, Asia Pacific, and the Middle East & Africa. With a market share surpassing 45%, North America led the industry in 2015. This region is propelled by high incidence of respiratory tract infections. Governmental initiatives, such as PAHO (Pan American Health Organization) may significantly contribute to market demand over the next couple of years. As per this initiative, it is absolutely necessary to rule out the possibilities of infections & metabolic defects in new borns.

Asia Pacific may register a high growth rate from 2016 to 2024. High incidence of infectious diseases fueled by moderate to poor living conditions propels this regional market. Other factors that may drive this region are improved healthcare infrastructure, high R&D funding, favourable government mandates, and steady technological advancements.

Prominent vendors in the worldwide industry are Thermo Fisher Scientific Inc.; Ortho Clinical Diagnostics; Abbott Laboratories; Roche Diagnostics; and Quest Diagnostics.

In 2016, Luminex Corporation, a U.S. based biotechnology company received U.S. FDA (Food and Drug Administration) approval for its ARIES Flu A/B & RSV Assay. This device helps detect three main respiratory pathogens namely, RSV and influenza A & B viruses. It delivers results within two hours. Furthermore, it is equipped with a panel customization feature that gives it the ability to report the required results only.

Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/organic-chemicals-industry

About Us:
Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us:
Ryan Shaw
Hexa Research
Felton Office Plaza
6265 Highway 9
Felton, California 95018
United States
Phone: +1-800-489-3075
Email: [email protected]
Website - http://www.hexaresearch.com/